Cambridge Healthtech Institute’s 12th Annual
Display of Biologics
Leading the Way for New Classes of Therapy
11 November 2025
Phage, yeast, and mammalian display are essential tools for creating the vast arsenal of emerging biologic constructs, including multispecifics, ADCs, and immunotherapies. The integration of ML/AI to assess developability and enable optimization of candidates, along with computational modeling, have led to new workflows in the discovery engine. New methods of conditional activation and masking strategies allow biologics to hit the tumor before they become activated, reducing off-target toxicity and adverse events. Cambridge Healthtech Institute's Twelfth Annual Display of Biologics conference is the cornerstone of the PEGS Europe Summit, and will assemble pioneers advancing new classes of therapy.
Coverage will include, but is not limited to:
- Developing novel platforms for phage, yeast and mammalian display
- Embedding in silico design and ML/AI into novel workflows
- Enabling computationally designed repertoires of antibodies and biologics
- Identifying novel antibodies for autoimmune disease
- Addressing complex targets- ion channels, GPCRs
- Applying phage and mammalian display for optimizing therapeutic antibodies
The deadline for priority consideration is 28 March 2025.
All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
Opportunities for Participation: